Curtis Oltmans
Net worth: 39 900 $ as of 2026-08-30
Net worth: 39 900 $ as of 2026-08-30
Curtis G.
Oltmans is an Independent Director at Avenue Therapeutics, Inc. since 2021.
Mr. Oltmans is Chief Legal Officer & Head-External Affairs at Fulcrum Therapeutics, Inc. since 2020.
Mr. Oltmans was Secretary, Executive VP & General Counsel at Array BioPharma, Inc. from 2017 to 2019.
Mr. Oltmans was Vice President & Head-Litigation at Davita Kidney Care, Inc. from 2019 to 2020.
Mr. Oltmans was Vice President & General Counsel at Novo Nordisk, Inc. from 2005 to 2017.
Mr. Oltmans was Associate General Counsel at Eli Lilly & Co. from 1992 to 2005.
Mr. Oltmans was Associate at Shook, Hardy & Bacon LLP in 1992.
Mr. Oltmans was Director at Boys & Girls Club of Trenton & Mercer County.
Mr. Oltmans completed undergraduate studies at the University of Nebraska in 1985.
Mr. Oltmans completed graduate studies at the University of Nebraska College of Law in 1988.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 10,252 ( 0.01% ) | 39 880 $ | 2026-08-30 | |
| 2025-11-24 | 44 ( 0% ) | 20 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Public Communications Contact | - |
| AVENUE THERAPEUTICS, INC. | Director/Board Member | 2021-03-31 |
| Companies | Position | End |
|---|---|---|
Davita Kidney Care, Inc.
Davita Kidney Care, Inc. Medical/Nursing ServicesHealth Services Provides kidney care services | Corporate Officer/Principal | 2020-10-31 |
| ARRAY TECHNOLOGIES, INC. | General Counsel | 2019-03-18 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | General Counsel | 2017-07-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2005-05-31 |
Shook, Hardy & Bacon LLP
Shook, Hardy & Bacon LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 1991-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Shook, Hardy & Bacon LLP
Shook, Hardy & Bacon LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Boys & Girls Club of Trenton & Mercer County | |
University of Nebraska College of Law
University of Nebraska College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Davita Kidney Care, Inc.
Davita Kidney Care, Inc. Medical/Nursing ServicesHealth Services Provides kidney care services | Health Services |
Select your edition
All financial news and data tailored to specific country editions